Another study demonstrated that TREM-2 suppresses inflammatory responses by negatively regulating the p38 MAPK signaling pathway, alleviating neuroinflammation and cognitive impairment caused by the combined effects of diabetes mellitus (DM) and chronic cerebral hypoperfusion (CCH) on the organism (91). This evidence concerns the gene TREM2 and columnar cell hyperplasia of the breast.